Xiaobo Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaobo Huang has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Lizhe An
Peking University People's Hospital
8 shared publicationsQingquan Xu
The Department of Urology, Peking University People’s Hospital, Beijing, China
7 shared publications- Liu-Lin Xiong
Brain-Computer Interface Medical Center, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China
6 shared publications Yang Hong
The Department of Urology, Peking University People’s Hospital, Beijing, China
6 shared publicationsLiulin Xiong
Peking University People's Hospital
5 shared publicationsLiang Chen
The Department of Urology, Peking University People’s Hospital, Beijing, China
4 shared publications
Latest Publications
- Open Access
- 8 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (10) , e37374
Composition analysis of renal and ureteral calculi in a single center in northern China in the past decade
The current report aimed to evaluate the characteristics of stone composition in 3637 renal and ureteral calculi patients in a single center while clarifying its relationship with sex, age, and time. Out of 3637 cases of upper urinary tract stones, stone specimens were analyzed retrospectively. There were 2373 male patients aged 6 months-87 years, with an average age of 44.73 ± 15.63 years, and 1264 female patients aged 4 months-87 years, with an average age of 46.84 ± 16.00 years. The male-female ratio was 1.88:1. Five hundred twelve patients had ureteral calculi, and 3125 had renal calculi. The SPSS software helped analyze the relationship between renal and ureteral calculi composition and sex, age, and time. Stone composition demonstrated 2205 cases of calcium oxalate stones (60.6%), 518 carbonate apatite (14.2%), 386 uric acids (10.6%), 232 magnesium ammonium phosphate (6.4%), 117 calcium phosphate (3.2%), 76 cystine (2.1%), 47 sodium urate (1.3%), 31 others (0.9%), and 25 ammonium urate (0.7%) cases. The overall male-to-female sex ratio was 1.88:1. Stones in the upper urinary tract were significantly more frequent in men than in women between the ages of 31 and 60. However, such stones were significantly more frequent in women than men over 80 (P < .05). Cystine, Sodium urate, Carbonated apatite, and uric acid indicated significant differences between different age categories (all P < .001). Stone composition analyses revealed that the frequency of calcium oxalate calculi has increased annually, while cystine and carbonated apatite incidences have dropped annually over the past decade. The components of renal and ureteral calculi vary significantly based on age and sex, with calcium oxalate calculi being more frequent in men while magnesium ammonium phosphate stones are more frequent in female patients. The age between 31 and 60 years is the most prevalent for renal and ureteral calculi in men and women.
- 8 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (10) , e37374
Open AccessComposition analysis of renal and ureteral calculi in a single center in northern China in the past decade
The current report aimed to evaluate the characteristics of stone composition in 3637 renal and ureteral calculi patients in a single center while clarifying its relationship with sex, age, and time. Out of 3637 cases of upper urinary tract stones, stone specimens were analyzed retrospectively. There were 2373 male patients aged 6 months-87 years, with an average age of 44.73 ± 15.63 years, and 1264 female patients aged 4 months-87 years, with an average age of 46.84 ± 16.00 years. The male-female ratio was 1.88:1. Five hundred twelve patients had ureteral calculi, and 3125 had renal calculi. The SPSS software helped analyze the relationship between renal and ureteral calculi composition and sex, age, and time. Stone composition demonstrated 2205 cases of calcium oxalate stones (60.6%), 518 carbonate apatite (14.2%), 386 uric acids (10.6%), 232 magnesium ammonium phosphate (6.4%), 117 calcium phosphate (3.2%), 76 cystine (2.1%), 47 sodium urate (1.3%), 31 others (0.9%), and 25 ammonium urate (0.7%) cases. The overall male-to-female sex ratio was 1.88:1. Stones in the upper urinary tract were significantly more frequent in men than in women between the ages of 31 and 60. However, such stones were significantly more frequent in women than men over 80 (P < .05). Cystine, Sodium urate, Carbonated apatite, and uric acid indicated significant differences between different age categories (all P < .001). Stone composition analyses revealed that the frequency of calcium oxalate calculi has increased annually, while cystine and carbonated apatite incidences have dropped annually over the past decade. The components of renal and ureteral calculi vary significantly based on age and sex, with calcium oxalate calculi being more frequent in men while magnesium ammonium phosphate stones are more frequent in female patients. The age between 31 and 60 years is the most prevalent for renal and ureteral calculi in men and women.
- Open Access
- 16 November 2022
- Published by Springer Nature in BMC Surgery
- Vol. 22 (1) , 1-7
Efficacy and safety of percutaneous nephrolithotripsy in elderly patients: a retrospective study
Background: Percutaneous nephrolithotripsy (PCNL) is difficult to perform for elderly patients; thus, this study aimed to assess its efficacy and safety in elderly patients aged > 70 years, note any associations between outcomes and patient characteristics, and summarize relevant themes and observations. Methods: Data from patients older than 70 years who had undergone PCNL for upper urinary tract calculi between January 2016 and January 2021 was retrospectively analyzed. Risk factors for postoperative complications and residual stones were analyzed using multivariate logistic regression. Results: A total of 116 elderly patients underwent 122 PCNL operations, of which six underwent secondary PCNL operations, and all of which were successfully completed. The average age was 74.6 ± 4.3 years; the average stone size and operation time were 3.5 ± 1.8 (1.2–11 cm), and 71.8 ± 34.1 min, respectively. Of the participants, 16 or 13.8% had postoperative complications and 29 (25%) had residual stones after operation. The stone free rate was 75%. Multivariate analysis revealed that an American Score of Anesthesiology III was an independent risk factor for postoperative complications (odds ratio [OR] = 4.453, p = 0.031), and staghorn calculi were independent risk factors for postoperative residual calculi (OR = 31.393, p = 0.001). Conclusion: PCNL was shown to be safe and effective for elderly patients aged > 70 years. Further, ASA III was an independent risk factor for postoperative complications, and staghorn calculi were independent risk factors for postoperative residual calculi in elderly patients.
- 16 November 2022
- Published by Springer Nature in BMC Surgery
- Vol. 22 (1) , 1-7
Open AccessEfficacy and safety of percutaneous nephrolithotripsy in elderly patients: a retrospective study
Background: Percutaneous nephrolithotripsy (PCNL) is difficult to perform for elderly patients; thus, this study aimed to assess its efficacy and safety in elderly patients aged > 70 years, note any associations between outcomes and patient characteristics, and summarize relevant themes and observations. Methods: Data from patients older than 70 years who had undergone PCNL for upper urinary tract calculi between January 2016 and January 2021 was retrospectively analyzed. Risk factors for postoperative complications and residual stones were analyzed using multivariate logistic regression. Results: A total of 116 elderly patients underwent 122 PCNL operations, of which six underwent secondary PCNL operations, and all of which were successfully completed. The average age was 74.6 ± 4.3 years; the average stone size and operation time were 3.5 ± 1.8 (1.2–11 cm), and 71.8 ± 34.1 min, respectively. Of the participants, 16 or 13.8% had postoperative complications and 29 (25%) had residual stones after operation. The stone free rate was 75%. Multivariate analysis revealed that an American Score of Anesthesiology III was an independent risk factor for postoperative complications (odds ratio [OR] = 4.453, p = 0.031), and staghorn calculi were independent risk factors for postoperative residual calculi (OR = 31.393, p = 0.001). Conclusion: PCNL was shown to be safe and effective for elderly patients aged > 70 years. Further, ASA III was an independent risk factor for postoperative complications, and staghorn calculi were independent risk factors for postoperative residual calculi in elderly patients.
- Open Access
- 7 September 2022
- Published by Springer Nature in BMC Urology
- Vol. 22 (1) , 1-6
Mini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy and its initial clinical application
To assess the outcome of the mini-track, mini-nephroscopy, mini ultrasonic probe percutaneous nephrolithotomy for upper ureteral and kidney stones. We collected data of 53 patients (55 kidney units) who underwent mini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy between September 2020 and March 2021. The study included single and upper ureteral stones from 12 kidneys, multiple stones from 28 kidneys, and staghorn stones from 15 kidneys. The mean operative duration was 50.6 min, ranging from 15 to 200 min, whereas the mean lithotripsy and stone removal time was 17.2 min (3–45 min). Moreover, the mean postoperative length of stay was 4.0 days (1–7 days). Besides, the stone-free rate (SFR) of discharge was 89.1% (49/55). The mean hemoglobin drop was 15.3 mg/dL, ranging 1–32 mg/dL. Out of the total cases, only 4 of them displayed minor complications. The outcomes of < 40 mm versus ≥ 40 mm calculi were compared by performing subgroup analysis. The results demonstrated a longer operation duration (65.2 vs. 40.2 min), higher complication rate (13.0% vs. 3.3%), and lower SFR in the ≥ 40 mm calculi subgroup. In summary, mini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy is an effective and safe method to treat patients with upper ureteral and kidney calculi. This is especially significant for the stone size of 20–40 mm, demonstrating excellent SFR and a lower complication rate.
- 7 September 2022
- Published by Springer Nature in BMC Urology
- Vol. 22 (1) , 1-6
Open AccessMini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy and its initial clinical application
To assess the outcome of the mini-track, mini-nephroscopy, mini ultrasonic probe percutaneous nephrolithotomy for upper ureteral and kidney stones. We collected data of 53 patients (55 kidney units) who underwent mini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy between September 2020 and March 2021. The study included single and upper ureteral stones from 12 kidneys, multiple stones from 28 kidneys, and staghorn stones from 15 kidneys. The mean operative duration was 50.6 min, ranging from 15 to 200 min, whereas the mean lithotripsy and stone removal time was 17.2 min (3–45 min). Moreover, the mean postoperative length of stay was 4.0 days (1–7 days). Besides, the stone-free rate (SFR) of discharge was 89.1% (49/55). The mean hemoglobin drop was 15.3 mg/dL, ranging 1–32 mg/dL. Out of the total cases, only 4 of them displayed minor complications. The outcomes of < 40 mm versus ≥ 40 mm calculi were compared by performing subgroup analysis. The results demonstrated a longer operation duration (65.2 vs. 40.2 min), higher complication rate (13.0% vs. 3.3%), and lower SFR in the ≥ 40 mm calculi subgroup. In summary, mini-track, mini-nephroscopy, mini-ultrasonic probe percutaneous nephrolithotomy is an effective and safe method to treat patients with upper ureteral and kidney calculi. This is especially significant for the stone size of 20–40 mm, demonstrating excellent SFR and a lower complication rate.
- Open Access
- 31 March 2022
- Published by Springer Nature in BMC Anesthesiology
- Vol. 22 (1) , 1-8
Nomogram for predicting risk factor of urosepsis in patients with diabetes after percutaneous nephrolithotomy
Background: Urosepsis is an infectious complication after percutaneous nephrolithotomy (PCNL). This study aimed to analyze the perioperative factors related to urosepsis after PCNL for upper urinary calculi and establish a nomogram to predict the probability of postoperative urosepsis based on the risk factors. Methods: The Clinical data of one-stage PCNL for upper urinary stones in patients already diagnosed with type 2 diabetes between June 2010 and June 2020 were retrospectively analyzed. The patients were divided into two groups according to whether urosepsis occurred after surgery, and univariate and multivariate logistic regression analyses evaluated the risk factors for urosepsis. Moreover, the corresponding nomogram prediction model was determined by the regression coefficient. Results: All 366 patients with diabetes underwent one-stage PCNL. Seventy-one (19.4%) patients had urosepsis after surgery, and their hospitalization time was longer than that of patients without urosepsis. Moreover, the incidence of non-infection-related complications was higher. Multivariate logistic regression analysis revealed four independent risk factors associated with postoperative urosepsis, including positive urine nitrite (odds ratio [OR] = 3.326, P = 0.007), positive urine culture (OR = 2.213, P = 0.023), intraoperative hypotension (OR = 8.968, P < 0.001), and staghorn calculi (OR = 3.180, P = 0.002). The above independent risk factors were used as variables to construct the nomogram. The nomogram model was internally validated. The calculated concordance index was 0.824. The Hosmer–Lemeshow goodness-of-fit test was performed (P = 0.972 > 0.05). The area under the curve of this model was 0.831, indicating that the nomogram model had good accuracy in predicting the probability of urosepsis in patients who underwent PCNL with diabetes and had good consistency with the actual risk. Conclusion: Positive urine culture, positive urine nitrite, staghorn calculi, and intraoperative hypotension were independent risk factors for urosepsis in patients who underwent one-stage PCNL with diabetes. The new nomogram could accurately assess the risk of urosepsis after PCNL in patients with diabetes.
- 31 March 2022
- Published by Springer Nature in BMC Anesthesiology
- Vol. 22 (1) , 1-8
Open AccessNomogram for predicting risk factor of urosepsis in patients with diabetes after percutaneous nephrolithotomy
Background: Urosepsis is an infectious complication after percutaneous nephrolithotomy (PCNL). This study aimed to analyze the perioperative factors related to urosepsis after PCNL for upper urinary calculi and establish a nomogram to predict the probability of postoperative urosepsis based on the risk factors. Methods: The Clinical data of one-stage PCNL for upper urinary stones in patients already diagnosed with type 2 diabetes between June 2010 and June 2020 were retrospectively analyzed. The patients were divided into two groups according to whether urosepsis occurred after surgery, and univariate and multivariate logistic regression analyses evaluated the risk factors for urosepsis. Moreover, the corresponding nomogram prediction model was determined by the regression coefficient. Results: All 366 patients with diabetes underwent one-stage PCNL. Seventy-one (19.4%) patients had urosepsis after surgery, and their hospitalization time was longer than that of patients without urosepsis. Moreover, the incidence of non-infection-related complications was higher. Multivariate logistic regression analysis revealed four independent risk factors associated with postoperative urosepsis, including positive urine nitrite (odds ratio [OR] = 3.326, P = 0.007), positive urine culture (OR = 2.213, P = 0.023), intraoperative hypotension (OR = 8.968, P < 0.001), and staghorn calculi (OR = 3.180, P = 0.002). The above independent risk factors were used as variables to construct the nomogram. The nomogram model was internally validated. The calculated concordance index was 0.824. The Hosmer–Lemeshow goodness-of-fit test was performed (P = 0.972 > 0.05). The area under the curve of this model was 0.831, indicating that the nomogram model had good accuracy in predicting the probability of urosepsis in patients who underwent PCNL with diabetes and had good consistency with the actual risk. Conclusion: Positive urine culture, positive urine nitrite, staghorn calculi, and intraoperative hypotension were independent risk factors for urosepsis in patients who underwent one-stage PCNL with diabetes. The new nomogram could accurately assess the risk of urosepsis after PCNL in patients with diabetes.
- Open Access
- 15 December 2021
- Published by Springer Nature in Research Square
Midstream Urine Culture Had a Higher Predictive Value of Post-PNL SIRS in Patients Without Upper Urinary Tract Obstruction
Introduction: Systemic inflammatory response syndrome (SIRS) is a common complication of percutaneous nephrolithotomy (PNL). Midstream urine culture (MUC) is reported to be associated with postoperative SIRS, but this correlation is uncertain, as MUC may not represent infection of obstructed urine in patients with upper urinary tract obstruction (UUTO). Instead, for patients without UUTO, positive MUC may be an indicator of intrarenal infection. The aim of this study was to investigate whether MUC had a higher predictive value in patients without UUTO. Materials and Methods The data of 175 patients who underwent PNL between September 2015 and June 2016 were retrospectively reviewed. Preoperative and intraoperative factors including MUC were collected and analyzed. The primary endpoint was development of SIRS. Subgroup analysis according to the presence of UUTO was conducted. Results Generally, patients who suffered SIRS had a higher incidence of positive MUC (56%[25/45] vs. 32%[41/130], p=0.005). Subgroup analysis showed that among patients without UUTO, positive MUC (75%[13/17] vs. 33%[13/39], p=0.003) was still associated with development of SIRS. Among patients with UUTO, however, there was no obvious correlation between positive MUC and SIRS. Multivariate analysis controlling for age, previous ipsilateral kidney surgery, multiple tracts, and blood creatinine conducted in patients without UUTO demonstrated that positive MUC (odds ratio [OR] = 6.419, 95% confidence interval [CI]: 1.424-28.942, p=0.016) was still associated with development of SIRS. The rate of positive urine culture was 37.7% (66/72), 72 isolates of 24 species were reported, including 6 patients with mixed infection and 2 patients with fungi infection. Gram-negative bacteria accounted for a large proportion of all isolates (68.1%), and Escherichia coli was the most common bacteria (34.7%). Conclusions MUC had a higher predictive value of post-PNL SIRS in patients without UUTO.
- 15 December 2021
- Published by Springer Nature in Research Square
Open AccessMidstream Urine Culture Had a Higher Predictive Value of Post-PNL SIRS in Patients Without Upper Urinary Tract Obstruction
Introduction: Systemic inflammatory response syndrome (SIRS) is a common complication of percutaneous nephrolithotomy (PNL). Midstream urine culture (MUC) is reported to be associated with postoperative SIRS, but this correlation is uncertain, as MUC may not represent infection of obstructed urine in patients with upper urinary tract obstruction (UUTO). Instead, for patients without UUTO, positive MUC may be an indicator of intrarenal infection. The aim of this study was to investigate whether MUC had a higher predictive value in patients without UUTO. Materials and Methods The data of 175 patients who underwent PNL between September 2015 and June 2016 were retrospectively reviewed. Preoperative and intraoperative factors including MUC were collected and analyzed. The primary endpoint was development of SIRS. Subgroup analysis according to the presence of UUTO was conducted. Results Generally, patients who suffered SIRS had a higher incidence of positive MUC (56%[25/45] vs. 32%[41/130], p=0.005). Subgroup analysis showed that among patients without UUTO, positive MUC (75%[13/17] vs. 33%[13/39], p=0.003) was still associated with development of SIRS. Among patients with UUTO, however, there was no obvious correlation between positive MUC and SIRS. Multivariate analysis controlling for age, previous ipsilateral kidney surgery, multiple tracts, and blood creatinine conducted in patients without UUTO demonstrated that positive MUC (odds ratio [OR] = 6.419, 95% confidence interval [CI]: 1.424-28.942, p=0.016) was still associated with development of SIRS. The rate of positive urine culture was 37.7% (66/72), 72 isolates of 24 species were reported, including 6 patients with mixed infection and 2 patients with fungi infection. Gram-negative bacteria accounted for a large proportion of all isolates (68.1%), and Escherichia coli was the most common bacteria (34.7%). Conclusions MUC had a higher predictive value of post-PNL SIRS in patients without UUTO.
- 9 December 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 14 (3) , 170-177
Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males
Objectives: Obesity and metabolic status are both modifiable risk factors of lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH). However, the association between metabolically healthy obesity (MHO) and LUTS/BPH is largely unexplored. This study aimed to investigate the risk of LUTS/BPH among different metabolic syndrome‐body mass index (MetS‐BMI) phenotypes in a cohort of Chinese males.Methods: A total of 3321 males from the China Health and Retirement Longitudinal Study (CHARLS) without history of LUTS/BPH at baseline were included into the analyses. Participants were categorized into six mutually exclusive groups according to presence or absence of MetS combined with BMI status: metabolically healthy normal weight/overweight/obesity (MHN/MHOW/MHO) and metabolically unhealthy normal weight/overweight/obesity (MUN/MUOW/MUO). Adjusted odds ratios (OR) and 95% CI of LUTS/BPH across MetS‐BMI categories were estimated with multivariable logistic regression models.Results: A total of 394 (11.86%) participants developed LUTS/BPH during the follow‐up. After adjusting for age, educational level, smoking status, drinking status, and BMI change, the multivariable‐adjusted OR (95% CI) for incident LUTS/BPH comparing MUO, MHO, MUOW, MHOW, and MUN with MHN were 1.99 (1.23‐3.22), 2.04 (1.14‐3.66), 1.61 (1.11‐2.34), 1.45 (1.02‐2.05), and 0.91 (0.54‐1.56), respectively.Conclusions: MHO and MHOW were risk populations of LUTS/BPH, suggesting that overweight and obesity can independently contribute to LUTS/BPH, even among metabolically healthy individuals. These findings emphasize metabolically healthy individuals may still benefit from maintaining normal body weight to prevent LUTS/BPH. Our findings also support that those recommendations for LUTS/BPH should highlight the importance of maintaining metabolic health across all BMI groups among Chinese males.
- 9 December 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 14 (3) , 170-177
Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males
Objectives: Obesity and metabolic status are both modifiable risk factors of lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH). However, the association between metabolically healthy obesity (MHO) and LUTS/BPH is largely unexplored. This study aimed to investigate the risk of LUTS/BPH among different metabolic syndrome‐body mass index (MetS‐BMI) phenotypes in a cohort of Chinese males.Methods: A total of 3321 males from the China Health and Retirement Longitudinal Study (CHARLS) without history of LUTS/BPH at baseline were included into the analyses. Participants were categorized into six mutually exclusive groups according to presence or absence of MetS combined with BMI status: metabolically healthy normal weight/overweight/obesity (MHN/MHOW/MHO) and metabolically unhealthy normal weight/overweight/obesity (MUN/MUOW/MUO). Adjusted odds ratios (OR) and 95% CI of LUTS/BPH across MetS‐BMI categories were estimated with multivariable logistic regression models.Results: A total of 394 (11.86%) participants developed LUTS/BPH during the follow‐up. After adjusting for age, educational level, smoking status, drinking status, and BMI change, the multivariable‐adjusted OR (95% CI) for incident LUTS/BPH comparing MUO, MHO, MUOW, MHOW, and MUN with MHN were 1.99 (1.23‐3.22), 2.04 (1.14‐3.66), 1.61 (1.11‐2.34), 1.45 (1.02‐2.05), and 0.91 (0.54‐1.56), respectively.Conclusions: MHO and MHOW were risk populations of LUTS/BPH, suggesting that overweight and obesity can independently contribute to LUTS/BPH, even among metabolically healthy individuals. These findings emphasize metabolically healthy individuals may still benefit from maintaining normal body weight to prevent LUTS/BPH. Our findings also support that those recommendations for LUTS/BPH should highlight the importance of maintaining metabolic health across all BMI groups among Chinese males.
- Open Access
- 1 November 2021
- Published by Springer Nature in Research Square
Identification of a FLG-wide-type bladder cancer subtype with poor prognosis and prediction use in immune checkpoint
Background Bladder cancer (BLCA) is one of most common urinary tract malignant tumor and immunotherapy have generated a great deal of interest in BLCA. Immune checkpoint blockade (ICB) therapy has significantly progressed the treatment of BLCA. Multiple studies have suggested that specific genetic mutations may serve as immune biomarkers for ICB therapy. Objective In this study, we aimed to investigate the role of mutations genes and subtypes in prognosis and immune checkpoint prediction in BLCA. Method Mutation information and expression profiles were acquired from The Cancer Genome Atlas (TCGA) database. Integrated bioinformatics analysis was carried out to explore the mutation genes of BLCA. Functional enrichment analysis Gene Ontology (GO) and Gene set enrichment analysis (GSEA) was conducted. The infiltrating immune cells and the prediction of ICB between different subtypes group were explored using immuCellAI algorithm. Results The mutation genes Filaggrin (FLG) gene were identified. Following the study on its subtypes and functional enrichment analysis, Sub2 of FLG-wide type was found to have relationships with poor prognosis and immune infiltration BLCA. What’s more, Sub2 of FLG-wide type may be used as a biomarker to predict the prognosis of BLCA patients receiving ICB. Conclusion This research provides a new basis and ideas for guiding the clinical application of BLCA immunotherapy.
- 1 November 2021
- Published by Springer Nature in Research Square
Open AccessIdentification of a FLG-wide-type bladder cancer subtype with poor prognosis and prediction use in immune checkpoint
Background Bladder cancer (BLCA) is one of most common urinary tract malignant tumor and immunotherapy have generated a great deal of interest in BLCA. Immune checkpoint blockade (ICB) therapy has significantly progressed the treatment of BLCA. Multiple studies have suggested that specific genetic mutations may serve as immune biomarkers for ICB therapy. Objective In this study, we aimed to investigate the role of mutations genes and subtypes in prognosis and immune checkpoint prediction in BLCA. Method Mutation information and expression profiles were acquired from The Cancer Genome Atlas (TCGA) database. Integrated bioinformatics analysis was carried out to explore the mutation genes of BLCA. Functional enrichment analysis Gene Ontology (GO) and Gene set enrichment analysis (GSEA) was conducted. The infiltrating immune cells and the prediction of ICB between different subtypes group were explored using immuCellAI algorithm. Results The mutation genes Filaggrin (FLG) gene were identified. Following the study on its subtypes and functional enrichment analysis, Sub2 of FLG-wide type was found to have relationships with poor prognosis and immune infiltration BLCA. What’s more, Sub2 of FLG-wide type may be used as a biomarker to predict the prognosis of BLCA patients receiving ICB. Conclusion This research provides a new basis and ideas for guiding the clinical application of BLCA immunotherapy.
- Open Access
- 1 May 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (5) , 5252-5259
Efficacy and safety of ultrasound-guided percutaneous nephrolithotomy for kidney calculi patients with ankylosing spondylitis: a retrospective single center analysis
Efficacy and safety of ultrasound-guided percutaneous nephrolithotomy for kidney calculi patients with ankylosing spondylitis: a retrospective single center analysis Mingrui Xia, Yang Hong, Lizhe An, Liulin Xiong, Xiaobo Huang, Qingquan Xu
- 1 May 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (5) , 5252-5259
Open AccessEfficacy and safety of ultrasound-guided percutaneous nephrolithotomy for kidney calculi patients with ankylosing spondylitis: a retrospective single center analysis
Efficacy and safety of ultrasound-guided percutaneous nephrolithotomy for kidney calculi patients with ankylosing spondylitis: a retrospective single center analysis Mingrui Xia, Yang Hong, Lizhe An, Liulin Xiong, Xiaobo Huang, Qingquan Xu
- Open Access
- 1 March 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (3) , 2776-2780
The impact of metabolic syndrome on the safety and efficacy of flexible ureterorenoscopy
The impact of metabolic syndrome on the safety and efficacy of flexible ureterorenoscopy Jun Liu, Yang Hong, Bo Yang, Xiaobo Huang, Qingquan Xu, Liulin Xiong, Xiaofeng Wang
- 1 March 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (3) , 2776-2780
Open AccessThe impact of metabolic syndrome on the safety and efficacy of flexible ureterorenoscopy
The impact of metabolic syndrome on the safety and efficacy of flexible ureterorenoscopy Jun Liu, Yang Hong, Bo Yang, Xiaobo Huang, Qingquan Xu, Liulin Xiong, Xiaofeng Wang
- Open Access
- 1 February 2021
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 10 (2) , 636-642
Effects of high-sodium diet on lithogenesis in a rat experimental model of calcium oxalate stones
Background: This study aimed to investigate the effects of a high- and low-sodium diets on lithogenesis in a rat experimental model of calcium oxalate stones. Methods: Twenty male Wistar rats were randomly divided into four groups; group A: 4% NaCl+1% ethylene glycol (EG); group B: 8% NaCl+1% EG; group C: 8% NaCl+normal drinking-water; group D: 1% EG +normal diet. All rats were sacrificed 4 weeks later, and blood samples were collected from the heart. The kidneys were collected for Von Kossa staining to evaluate the formation of calcium-containing crystals. The last 24-h urine samples were also gathered for metabolic analysis. Results: Von Kossa staining demonstrated that the rats in both group A and group B had significantly more renal calcium crystals than those in group D. However, 24-h urinary volume increased significantly (142.26±20.91 mL) in group B compared with group A (100.52±28.23 mL), group C (107.36±14.24 mL), group D (40.79±8.71 mL) (P=0.004, 0.012, and 0.000 respectively). Level of urine sodium (Na), potassium (K), chlorine (Cl), and calcium (Ca), urea nitrogen were significantly higher in group B compared with group D. The urine phosphorus, oxalate, and creatinine levels; urine specific gravity; and urine PH were similar between group B and group D. The level of serum sodium was higher in group B (151.26±4.06 mmol/L) compared with group D (145.56±1.12 mmol/L) (P=0.002). Conclusions: A high sodium intake might increase the risk of lithogenesis in susceptible individuals (given by EG) or in individuals with water restriction.
- 1 February 2021
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 10 (2) , 636-642
Open AccessEffects of high-sodium diet on lithogenesis in a rat experimental model of calcium oxalate stones
Background: This study aimed to investigate the effects of a high- and low-sodium diets on lithogenesis in a rat experimental model of calcium oxalate stones. Methods: Twenty male Wistar rats were randomly divided into four groups; group A: 4% NaCl+1% ethylene glycol (EG); group B: 8% NaCl+1% EG; group C: 8% NaCl+normal drinking-water; group D: 1% EG +normal diet. All rats were sacrificed 4 weeks later, and blood samples were collected from the heart. The kidneys were collected for Von Kossa staining to evaluate the formation of calcium-containing crystals. The last 24-h urine samples were also gathered for metabolic analysis. Results: Von Kossa staining demonstrated that the rats in both group A and group B had significantly more renal calcium crystals than those in group D. However, 24-h urinary volume increased significantly (142.26±20.91 mL) in group B compared with group A (100.52±28.23 mL), group C (107.36±14.24 mL), group D (40.79±8.71 mL) (P=0.004, 0.012, and 0.000 respectively). Level of urine sodium (Na), potassium (K), chlorine (Cl), and calcium (Ca), urea nitrogen were significantly higher in group B compared with group D. The urine phosphorus, oxalate, and creatinine levels; urine specific gravity; and urine PH were similar between group B and group D. The level of serum sodium was higher in group B (151.26±4.06 mmol/L) compared with group D (145.56±1.12 mmol/L) (P=0.002). Conclusions: A high sodium intake might increase the risk of lithogenesis in susceptible individuals (given by EG) or in individuals with water restriction.